Lucid Group built a business around an awkward truth in medicine: approval is only the beginning. Its job is to move evidence through the far messier machinery of belief, behaviour and clinical practice.

The Apten co-founder went from supply-chain analytics and zero sales experience to running a small, profitable AI company. His operating lesson is plain: follow-up is a system, and focus sometimes means firing revenue.
Aktana spent years turning pharma’s scattered customer data into a daily recommendation engine. Now, under PharmaForceIQ, its field intelligence is being stitched to digital orchestration in a bid to close one of life sciences’ most expensive gaps.